fda
2 records
FDA Drug Recall: Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only,
2026-01-14
Class II — Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
View Source
FDA Drug Recall: Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only
2026-01-14
Class II — Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
View Source
fda_adverse
1 records
FDA AE Manufacturer: SpecGx LLC
Drug adverse event reporter — Product: OXYCODONE AND ACETAMINOPHEN
View Source
ny_corps
2 records
NY Corp: SPECGX HOLDINGS LLC
2019-10-18
DOMESTIC LIMITED LIABILITY COMPANY | County: New York | Jurisdiction: New York
View Source
NY Corp: SPECGX LLC
2017-05-04
FOREIGN LIMITED LIABILITY COMPANY | County: Delaware | Jurisdiction: Delaware
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.